Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (LLY)
NYSE:LLY
LLY Analyst Ratings
Strong Buy
19 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LLY Stock 12 Month Forecast
Average Price Target
$1,003.60
▲(13.46% Upside)
| Highest Price Target$1,124 | Average Price Target$1,004 | Lowest Price Target$888.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
04/22/25
Bernstein
Reiterated
04/22/25
Leerink Partners
Reiterated
04/21/25
Cantor Fitzgerald
Initiated
04/21/25
Morgan Stanley
Reiterated
04/21/25
Citi
Reiterated
04/21/25
Truist Financial
Reiterated
04/21/25
BMO Capital
Reiterated
04/20/25
J.P. Morgan
Reiterated
04/17/25
Guggenheim
Reiterated
04/14/25
Goldman Sachs
$892→$888
Buy
0.39%
Upside
Upgraded
04/08/25
Eli Lilly & Co.: Strategic Market Leadership and Growth Potential Justify Buy Rating
TD Cowen
$900→$1,050
Buy
18.71%
Upside
Reiterated
04/02/25
TD Cowen Sticks to Its Buy Rating for Eli Lilly & Co (LLY)
Wells Fargo
$1,100
Buy
24.36%
Upside
Reiterated
03/31/25
Analysts Conflicted on These Healthcare Names: Boston Scientific (NYSE: BSX), Cabaletta Bio (NASDAQ: CABA) and Eli Lilly & Co (NYSE: LLY)
UBS
$1,100
Buy
24.36%
Upside
Reiterated
03/24/25
UBS reiterates Buy Rating on Eli Lilly (LLY)UBS analyst Trung Huynh reiterated a Buy rating and $1,100.00 price target on Eli Lilly (NYSE: LLY).
Jefferies
$1,020
Buy
15.31%
Upside
Reiterated
03/24/25
Jefferies reiterates Buy Rating on Eli Lilly (LLY)Jefferies analyst Akash Tewari reiterated a Buy rating and $1,020.00 price target on Eli Lilly (NYSE: LLY)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
04/22/25
Bernstein
Reiterated
04/22/25
Leerink Partners
Reiterated
04/21/25
Cantor Fitzgerald
Initiated
04/21/25
Morgan Stanley
Reiterated
04/21/25
Citi
Reiterated
04/21/25
Truist Financial
Reiterated
04/21/25
BMO Capital
Reiterated
04/20/25
J.P. Morgan
Reiterated
04/17/25
Guggenheim
Reiterated
04/14/25
Goldman Sachs
$892→$888
Buy
0.39%
Upside
Upgraded
04/08/25
Eli Lilly & Co.: Strategic Market Leadership and Growth Potential Justify Buy Rating
TD Cowen
$900→$1,050
Buy
18.71%
Upside
Reiterated
04/02/25
TD Cowen Sticks to Its Buy Rating for Eli Lilly & Co (LLY)
Wells Fargo
$1,100
Buy
24.36%
Upside
Reiterated
03/31/25
Analysts Conflicted on These Healthcare Names: Boston Scientific (NYSE: BSX), Cabaletta Bio (NASDAQ: CABA) and Eli Lilly & Co (NYSE: LLY)
UBS
$1,100
Buy
24.36%
Upside
Reiterated
03/24/25
UBS reiterates Buy Rating on Eli Lilly (LLY)UBS analyst Trung Huynh reiterated a Buy rating and $1,100.00 price target on Eli Lilly (NYSE: LLY).
Jefferies
$1,020
Buy
15.31%
Upside
Reiterated
03/24/25
Jefferies reiterates Buy Rating on Eli Lilly (LLY)Jefferies analyst Akash Tewari reiterated a Buy rating and $1,020.00 price target on Eli Lilly (NYSE: LLY)
Best Analysts Covering Eli Lilly & Co
Which Analyst Should I Follow If I Want to Buy LLY and Sell After:
1 Month
xxx
Success Rate
28/37 ratings generated profit
Average Return
+5.48%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.68% of your transactions generating a profit, with an average return of +5.48% per trade.
3 Months
xxx
Success Rate
28/37 ratings generated profit
Average Return
+10.42%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.68% of your transactions generating a profit, with an average return of +10.42% per trade.
1 Year
Success Rate
38/41 ratings generated profit
Average Return
+35.16%
reiterated a buy rating 6 days ago
Copying Geoff Meacham's trades and holding each position for 1 Year would result in 92.68% of your transactions generating a profit, with an average return of +35.16% per trade.
2 Years
xxx
Success Rate
40/41 ratings generated profit
Average Return
+66.50%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 97.56% of your transactions generating a profit, with an average return of +66.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LLY Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
1
2
2
1
1
Buy
51
49
60
63
58
Hold
3
5
2
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
55
56
64
66
59
Each month's total comprises the sum of three months' worth of ratings.
LLY Financial Forecast
LLY Stock Forecast FAQ
What is LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is 1,003.60.
What is LLY’s upside potential, based on the analysts’ average price target?
Eli Lilly & Co has 13.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LLY a Buy, Sell or Hold?
Eli Lilly & Co has a consensus rating of Strong Buy which is based on 19 buy ratings, 0 hold ratings and 0 sell ratings.
What is Eli Lilly & Co’s price target?
The average price target for Eli Lilly & Co is 1,003.60. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,124.00 ,the lowest forecast is $888.00. The average price target represents 13.46% Increase from the current price of $884.54.
The highest analyst price target is $1,124.00 ,the lowest forecast is $888.00. The average price target represents 13.46% Increase from the current price of $884.54.
What do analysts say about Eli Lilly & Co?
Eli Lilly & Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of LLY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.